Botma G J, Verhoeven A J, Jansen H
Department of Biochemistry, Cardiovascular Research Institute (COEUR), Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands.
Atherosclerosis. 2001 Feb 15;154(3):625-32. doi: 10.1016/s0021-9150(00)00478-0.
The common -216G-->A and -480C-->T substitutions in the promoter region of the human hepatic lipase (LIPC) gene show high allelic association, and are correlated with decreased hepatic lipase activity and increased high-density lipoprotein cholesterol levels. To test the functionality of these substitutions, CAT-reporter assays were performed in HepG2 cells. LIPC (-650/+48) but not (-650/+61) promoter constructs showed transcriptional activity. LIPC (-650/+48) constructs with both -216A and -480T exhibited significantly lower promoter activity (-45%) than the wild-type form. Activities of -289/+48 constructs were not significantly affected by the -216G-->A substitution. The -480C/T site lies within a binding region for Upstream Stimulatory Factor (USF). Gel-shift assays showed that the binding affinity of USF protein for HL specific oligonucleotides was decreased four-fold by the -480C-->T substitution. However, promoter activity of the -650/+48 constructs was not significantly affected by the -480C-->T substitution alone. Co-transfection of HepG2 cells with USF(43) cDNA yielded a similar dose-dependent increase in activity of all -650/+48 constructs; the absolute difference in promoter activity increased but the relative difference between the variant promoter forms was maintained. Our studies demonstrate that the common LIPC promoter variation is functional, which explains the association of the -480T allele with a lower hepatic lipase activity in man.
人类肝脂酶(LIPC)基因启动子区域常见的-216G→A和-480C→T替换显示出高度的等位基因关联,并且与肝脂酶活性降低和高密度脂蛋白胆固醇水平升高相关。为了测试这些替换的功能,在HepG2细胞中进行了CAT报告基因检测。LIPC(-650/+48)启动子构建体显示出转录活性,而(-650/+61)则没有。同时含有-216A和-480T的LIPC(-650/+48)构建体的启动子活性比野生型形式显著降低(-45%)。-289/+48构建体的活性不受-216G→A替换的显著影响。-480C/T位点位于上游刺激因子(USF)的结合区域内。凝胶迁移实验表明,-480C→T替换使USF蛋白与HL特异性寡核苷酸的结合亲和力降低了四倍。然而,-650/+48构建体的启动子活性单独不受-480C→T替换的显著影响。将HepG2细胞与USF(43) cDNA共转染,所有-650/+48构建体的活性都产生了类似的剂量依赖性增加;启动子活性的绝对差异增加,但变异启动子形式之间的相对差异保持不变。我们的研究表明,常见的LIPC启动子变异具有功能,这解释了-480T等位基因与人类较低肝脂酶活性的关联。